LensLinks: Issue 168

Musk's Neuralink Human Chip Trials, brought to you by Regiment LL'

Today in LensLinks:

  • The FDA finally approved Elon Musk's Neuralink chip for human trials.

  • Metaverse in 2023 and Beyond: What Recent Studies and Experts

  • Controversial Stablecoin Issuer Tether Plans to Start Mining Bitcoin

  • Crypto Trading Essentials: Navigating Mistakes, Ethereum Holdings, Smart Buying Strategies, and Bitcoin Investment Factors

  • Nvidia Joins $1 Trillion Valuation Club Thanks to the AI Boom

  • BRC-20 Tokens Surge: Explore the Hottest Projects Harnessing the Power of the Bitcoin Blockchain

  • How Is Commodity Tokenization A Feature Advantage for DeFi?

  • Academics Offer Important Insights Into How Crypto Markets Are Evolving

  • Crypto Traders Need to Pay Attention to Chinese Yuan

  • Singularity: 3 Human Super Talents AI Will Not Replace; What not to share with ChatGPT if you use it for work

  • ESG: Greenhushing And Metawashing

  • And Much, Much, More…

#regimentco #Neuralink #brc-20 #nvidia #stablecoin

QUOTABLE

“We are now confident that the Neuralink device is ready for humans”

- Elon Musk

NOTABLE

Metaverse & Gaming

Blockchain, Tokens & DeFi

Crypto Trading

Metaverse & Gaming - a little more…

Blockchain, Tokens & DeFi - a little more…

Crypto Trading - a little more…

The Singularity:
AI, Quantum Computing, Robotics, Bio-engineering & Other Stuff on the way

ESG (Environmental, Social & Governance)

Dear reader: You made it to the bottom. How about forwarding LensLinks to a friend or reposting/re-tweeting? Click the handy links at the top to do so easily. Thanks for reading.

Disclaimer: This note is distributed by Regiment, LLC for informational purposes only and is sourced from publicly available media reports. It is not an investment recommendation or solicitation for any investment. The information is current as of date and subject to change. In such case Regiment, LLC does not undertake to provide any updates. Recipients must be aware that any private, alternative investments discussed are speculative in nature, often illiquid, and subject to loss of capital.